Dr. Reddy's third-quarter profit surges on strong growth in emerging markets
- By Reuters |
- Feb 01, 2019
- Last Updated at 15:34 IST
Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 65.3 percent surge in quarterly profit on Friday, handily beating market expectations, helped by strong growth in emerging markets.
Third-quarter net profit came in at 5 billion rupees ($70.10 million), compared with 3.03 billion rupees a year earlier, the company said.
Analysts on average expected the Hyderabad-based company to post a profit of 3.94 billion rupees, according to Refinitiv data.
"We continued to improve our performance in the third quarter, supported by significant growth in emerging markets and India," Chief Executive Officer GV Prasad said.
Revenue from emerging markets rose 31 percent to 7.7 billion rupees, aided by new product launches, a pick-up in momentum in new markets and better volume offtake in existing markets, the company said.
Dr.Reddy's shares were trading 2.8 percent higher in a broader Mumbai market that was up 0.62 percent at 0940 GMT
RELATED NEWS
.jpg)
Posted on 19- Feb- 2019
Posted on 19- Feb- 2019
Posted on 19- Feb- 2019
Posted on 19- Feb- 2019
Posted on 18- Feb- 2019
Posted on 18- Feb- 2019
Posted on 18- Feb- 2019
Posted on 18- Feb- 2019
Posted on 18- Feb- 2019
Posted on 18- Feb- 2019
The Big Stories
Wall Street opens lower as U.S.-China trade talks resume... Read More
Germany, France agree industrial policy plan for Europe... Read More
Oil hovers below 2019 highs on OPEC cuts, trade talks in focus... Read More
India exempts small firms from angel tax to promote business... Read More
Palladium at record high, closes in on $1,500; gold gains... Read More
Despite sanctions, Iran's oil exports rise in early 2019 - sources... Read More
LIVE ADVISORY
TESTIMONIALS
SACHIN PATEL
Good performance services ..Keep up the good work!!! Really appreciate your effort.
SACHIN PATEL
Good performance services ..Keep up the good work!!! Really appreciate your effort.
Dr. Ravindra Dhivare
Advisorymandi.com is really appreciable . As they give proper calls & levels with proper SL. Advis... Read More
Dr. Ravindra Dhivare
Advisorymandi.com is really appreciable . As they give proper calls & levels with proper SL. Advisorymandi,com teaches us, how to trade in share market in proper way. Personalized services also tell you about your services like, phone calls, reminders & other suggestions are really very appreciable with polite conversations. Outstanding team effort as they are very cooperative , polite and helps in sorting out problems and queries in best possible manner.
SHAKTI
Working with Advisorymandi.com was the best decision of my life. The work is highly credible. A BIG... Read More
SHAKTI
Working with Advisorymandi.com was the best decision of my life. The work is highly credible. A BIG THANKS for their virtuoso services.
ADITYA
ADVISORYMANI.COM is a platform where you can know everything about share market and how to trade?It... Read More
ADITYA
ADVISORYMANI.COM is a platform where you can know everything about share market and how to trade?It is a best Platform for a beginner who has just started trading. Employee of advisorymandi are very friendly. They are always ready for you to help in any condition. From my opinion every beginner who wants to be a successful trader , they the should join "ADVISORYMANDI.COM"
MANDEEP
YOUR WORK SPEAKS VOLUMES OF THE KIND OF CONCEPTS IT IS-EFFICIENT,ORGANIZED and RESULT ORIENTED. WELL... Read More
MANDEEP
YOUR WORK SPEAKS VOLUMES OF THE KIND OF CONCEPTS IT IS-EFFICIENT,ORGANIZED and RESULT ORIENTED. WELL DONE!! ADVISORYMANDI.COM AND TEAM
OPINION POLL
Will Nifty breach 10600 till expiry?
- YES
- NO
- CAN'T SAY
